Senior Medical Director EMEA, Neurosciences

Das ist der Job

Senior Medical Director EMEA, Neurosciences Why Join Us?

Darum lohnt es sich

If you want to have a meaningful impact and grow professionally and personally, come join our team. This role partners closely with global, regional, and local cross‑functional teams to align development, evidence generation, and commercialization strategies.

Cross‑Functional Collaboration : Partner closely with Global Medical Affairs, Clinical Development, Regulatory Affairs, Market Access & HEOR, Commercial and Diagnostics teams to enable integrated execution across the development‑to‑commercial continuum.

Leadership & Influence : Provide matrix leadership and mentoring across regional medical teams, influence decisions at senior levels through scientific credibility and strategic thinking, and drive a culture of innovation, patient‑centricity, and operational excellence. Benefits Generous vacation time and public holidays observed by the company.

Benefits vary by region and country. Be a hero for our rare disease patients. At Ultragenyx, we fundamentally believe in taking real impactful action to care for the needs of patients and our people.

We pursue a vision to lead the future of rare disease medicine, challenging the status quo with innovative medicines at fair prices and a collaborative ecosystem to help patients. Our focus on culture creates a supportive and inclusive environment for learning and growth.

We aim to be an organization proud to work for our family, friends, and community. Position Summary The Senior Medical Director, Neuroscience – EMEA is a strategic medical leader responsible for the development and execution of the regional medical affairs strategy for the disease program across EMEA.

The role leads pre‑launch and launch readiness activities, shapes the integrated evidence plan, and builds strong external partnerships with key opinion leaders, investigators, and patient communities to advance scientific understanding and improve outcomes for people living with this rare neurogenetic condition.

Work Model Flex: The role typically requires onsite work 2‑3 days per week, with possible additional days as needed. Responsibilities Strategic Leadership : Define and lead the EMEA medical strategy for Angelman syndrome, aligned with global strategy and tailored to regional needs; contribute to global medical and cross‑functional governance.

Provide strategic input into clinical development, lifecycle management, and pipeline prioritization. Evidence Generation & Dissemination Strategy : Active contributor to the Integrated Evidence Generation Plan (IEP), ensuring EMEA needs and evidence gaps are represented. Generate clinically meaningful and payer‑relevant evidence.

Contribute to publication strategy, data dissemination, and scientific communications. Launch Excellence : Lead EMEA medical launch planning and execution, including disease awareness, diagnostic pathways, and treatment paradigm evolution, ensuring medical readiness across EMEA clusters.

Partner with market access to support HTA submissions and value proposition. External Engagement : Build and maintain strong relationships with key opinion leaders, clinical investigators, scientific societies, and patient advocacy groups. Act as a scientific ambassador for the therapeutic area within the region.

Medical Affairs Execution : Oversee execution of medical education strategies, congress planning, scientific material review, and approval, ensuring high scientific rigor and compliance. Requirements Advanced scientific or clinical degree (MD, PhD, PharmD). 8–12+ years in the pharmaceutical/biotech industry, with strong Medical Affairs experience.

Significant experience in rare diseases, neuroscience/neurodevelopmental disorders, and launch/pre‑launch settings in EMEA. Deep understanding of EMEA healthcare systems, HTA processes, and access challenges.

Proven ability to develop and execute regional strategies, lead without authority in complex matrix environments, translate science into clinical and payer‑relevant insights, and communicate effectively with stakeholders. Travel will be required (approx. 30% of time). Long‑term incentive and employee stock purchase plans or equivalent offerings.

Fitness reimbursement.

Equal Opportunity Employer Statement Ultragenyx Pharmaceutical is an equal‑opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status, and any other status or classification protected by applicable federal, state, and/or local laws.

Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law. Applicants can request an accommodation prior to accepting a job offer.

If you require reasonable accommodation in completing this application, or in any part of the recruitment process, you may contact Talent Acquisition by emailing talentacquisition@ultragenyx.com. Note: It is unlawful in Massachusetts to require a lie detector test as a condition of employment or continued employment.

Employers who violate this law may be subject to criminal penalties and civil liability. #J-18808-Ljbffr